Literature DB >> 9203943

Changes in barrier function of a model intestinal epithelium by intraepithelial lymphocytes require new protein synthesis by epithelial cells.

C T Taylor1, A Murphy, D Kelleher, A W Baird.   

Abstract

BACKGROUND: Elements of the mucosal immune system may play an important part in regulating epithelial barrier function in the intestinal tract. Intraepithelial lymphocytes (IELs) represent a subtype of immunocyte which is strategically placed to regulate epithelial function at most mucosal sites. AIMS AND METHODS: An IEL derived cell line (SC1) was used to examine its effects on the model epithelium T84--a tumour derived cell line which retains the phenotype of colonic crypt cells. Transepithelial electrical resistance (TER) was used as a marker of epithelial integrity.
RESULTS: Coculture of T84 cells with SC1 produced a significant fall in TER as did exposure of T84 monolayers to IEL derived supernatant. Recombinant interferon-gamma (rIFN gamma) also reduced TER in T84 monolayers. Cycloheximide prevented the effects of IEL supernatant and of rIFN gamma on TER. The fall in TER in response to rIFN gamma was attenuated by blocking antibodies, which did not alter the fall in resistance induced by IEL supernatant. Fractions of IEL supernatant, separated on the basis of size, evoked temporally distinct changes in TER. Ultrastructural studies support the hypothesis that the slow onset but severe fall in TER indicates catastrophic effects on the monolayer. The more rapid onset fall in TER was not associated with gross changes in monolayer morphology. Reduction of TER by IEL supernatant was not influenced by inhibitors of tyrosine phosphatase or of protein kinase C. Although herbimycin did reduce the rapid onset change in TER, the tyrosine kinase inhibitor genistein did not alter responses to IEL supernatant.
CONCLUSIONS: Mucosal T cells may influence barrier function by a process involving new protein synthesis by epithelial cells. This model may have relevance in some inflammatory conditions of the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203943      PMCID: PMC1027167          DOI: 10.1136/gut.40.5.634

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes.

Authors:  P Brandtzaeg; T S Halstensen; K Kett; P Krajci; D Kvale; T O Rognum; H Scott; L M Sollid
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

2.  Spontaneous in vitro evolution of lytic specificity of cytotoxic T lymphocyte clones isolated from murine intestinal epithelium.

Authors:  J R Klein; M F Kagnoff
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

Review 3.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

4.  Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes.

Authors:  S P Balk; E C Ebert; R L Blumenthal; F V McDermott; K W Wucherpfennig; S B Landau; R S Blumberg
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

5.  Tumor promoter-induced changes in the permeability of epithelial cell tight junctions.

Authors:  G K Ojakian
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

6.  Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors.

Authors:  T J O'Dell; E R Kandel; S G Grant
Journal:  Nature       Date:  1991-10-10       Impact factor: 49.962

7.  The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.

Authors:  M Graber; C H June; L E Samelson; A Weiss
Journal:  Int Immunol       Date:  1992-11       Impact factor: 4.823

8.  Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation.

Authors:  X J Fan; A Chua; C N Shahi; J McDevitt; P W Keeling; D Kelleher
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

9.  Adhesion molecules utilized in binding of intraepithelial lymphocytes to human enterocytes.

Authors:  D Kelleher; A Murphy; S Lynch; C O'Farrelly
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

10.  Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit.

Authors:  T M Mahon; L A O'Neill
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

View more
  7 in total

1.  Modulation of human enteric epithelial barrier and ion transport function by Peyer's patch lymphocytes.

Authors:  Jie Chen; Lai-Ling Tsang; Lok-Sze Ho; Dewi-K Rowlands; Jie-Ying Gao; Chuen-Pei Ng; Yiu-Wa Chung; Hsiao-Chang Chan
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

Review 2.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.

Authors:  L E M Willemsen; J P Hoetjes; S J H van Deventer; E A F van Tol
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

4.  Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition.

Authors:  Hua Yang; Irfan Kiristioglu; Yongyi Fan; Benjamin Forbush; D Keith Bishop; Paul A Antony; Hong Zhou; Daniel H Teitelbaum
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

5.  Production of interferon-gamma by activated T-cell receptor-alphabeta CD8alphabeta intestinal intraepithelial lymphocytes is required and sufficient for disruption of the intestinal barrier integrity.

Authors:  Christel Zufferey; Dominik Erhart; Leslie Saurer; Christoph Mueller
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

6.  Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition.

Authors:  Yongjia Feng; Daniel H Teitelbaum
Journal:  J Physiol       Date:  2013-06-10       Impact factor: 5.182

7.  Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators.

Authors:  A M Terrés; J M Pajares; A M Hopkins; A Murphy; A Moran; A W Baird; D Kelleher
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.